My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 129

    1.

    A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence.

    Naselli A, Introini C, Timossi L, Spina B, Fontana V, Pezzi R, Germinale F, Bertolotto F, Puppo P.

    Eur Urol. 2012 May;61(5):908-13. Epub 2012 Jan 20.

    PMID:
    22280855
    [PubMed - in process]

    Related citations

    2.

    Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers.

    Kandimalla R, van Tilborg AA, Kompier LC, Stumpel DJ, Stam RW, Bangma CH, Zwarthoff EC.

    Eur Urol. 2012 Jun;61(6):1245-56. Epub 2012 Jan 18.

    PMID:
    22284968
    [PubMed - in process]

    Related citations

    3.

    Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A new and highly prognostic system to discern T1 bladder cancer substage. Eur Urol 2012;61:378-84.

    Burger M, Otto W, Hartmann A.

    Eur Urol. 2012 Apr;61(4):e31-2; author reply e33-4. Epub 2012 Jan 11. No abstract available.

    PMID:
    22245308
    [PubMed - in process]

    Related citations

    4.

    Error occurred: cannot get document summary

    PMID:
    22244777

    5.

    Re: Sven van den Bosch, J. Alfred Witjes. Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review. Eur Urol 2011;60:493-500.

    Banerjee S, Kumar V.

    Eur Urol. 2012 Mar;61(3):e13. Epub 2011 Dec 22. No abstract available.

    PMID:
    22206799
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Re: Ben J. Challacombe, Bernard H. Bochner, Prokar Dasgupta, et al. The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications. Eur Urol 2011;60:767-75.

    Simonato A, Ennas M.

    Eur Urol. 2012 Apr;61(4):e29; author reply e30. Epub 2011 Dec 21. No abstract available.

    PMID:
    22206801
    [PubMed - in process]

    Related citations

    7.

    Error occurred: cannot get document summary

    PMID:
    22204750

    8.

    Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.

    Maurer T, Souvatzoglou M, Kübler H, Opercan K, Schmidt S, Herrmann K, Stollfuss J, Weirich G, Haller B, Gschwend JE, Schwaiger M, Krause BJ, Treiber U.

    Eur Urol. 2012 May;61(5):1031-8. Epub 2011 Dec 14.

    PMID:
    22196847
    [PubMed - in process]

    Related citations

    9.

    Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer.

    Rosenblatt R, Sherif A, Rintala E, Wahlqvist R, Ullén A, Nilsson S, Malmström PU; the Nordic Urothelial Cancer Group.

    Eur Urol. 2012 Jun;61(6):1229-1238. Epub 2011 Dec 13.

    PMID:
    22189383
    [PubMed - as supplied by publisher]

    Related citations

    10.

    A plea for long-term surveillance in bacillus Calmette-Guérin-treated non-muscle-invasive bladder cancer.

    Meijer RP, van Rhijn BW.

    Eur Urol. 2012 Mar;61(3):508-9. Epub 2011 Dec 7. No abstract available.

    PMID:
    22154727
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Reply from Authors re: J. Alfred Witjes. Prognosis of T1G3 Bladder Cancer: How Well Can We Predict Progression? Eur Urol 2012;62:126-7.

    Palou J, Rodríguez Faba O, Peña JA.

    Eur Urol. 2012 Jul;62(1):128-9. Epub 2011 Dec 7. No abstract available.

    PMID:
    22204748
    [PubMed - in process]

    Related citations

    12.

    Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.

    Efstathiou JA, Spiegel DY, Shipley WU, Heney NM, Kaufman DS, Niemierko A, Coen JJ, Skowronski RY, Paly JJ, McGovern FJ, Zietman AL.

    Eur Urol. 2012 Apr;61(4):705-11. Epub 2011 Nov 12.

    PMID:
    22101114
    [PubMed - in process]

    Related citations

    13.

    Prognosis of T1G3 Bladder Cancer: How Well Can We Predict Progression?

    Witjes JA.

    Eur Urol. 2012 Jul;62(1):126-7. Epub 2011 Nov 10. No abstract available.

    PMID:
    22093295
    [PubMed - in process]

    Related citations

    14.

    A new and highly prognostic system to discern T1 bladder cancer substage.

    van Rhijn BW, van der Kwast TH, Alkhateeb SS, Fleshner NE, van Leenders GJ, Bostrom PJ, van der Aa MN, Kakiashvili DM, Bangma CH, Jewett MA, Zlotta AR.

    Eur Urol. 2012 Feb;61(2):378-84. Epub 2011 Oct 25.

    PMID:
    22036775
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Female Gender and Carcinoma In Situ in the Prostatic Urethra Are Prognostic Factors for Recurrence, Progression, and Disease-Specific Mortality in T1G3 Bladder Cancer Patients Treated With Bacillus Calmette-Guérin.

    Palou J, Sylvester RJ, Faba OR, Parada R, Peña JA, Algaba F, Villavicencio H.

    Eur Urol. 2012 Jul;62(1):118-25. Epub 2011 Oct 25.

    PMID:
    22101115
    [PubMed - in process]

    Related citations

    16.

    Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.

    Shariat SF, Ehdaie B, Rink M, Cha EK, Svatek RS, Chromecki TF, Fajkovic H, Novara G, David SG, Daneshmand S, Fradet Y, Lotan Y, Sagalowsky AI, Clozel T, Bastian PJ, Kassouf W, Fritsche HM, Burger M, Izawa JI, Tilki D, Abdollah F, Chun FK, Sonpavde G, Karakiewicz PI, Scherr DS, Gonen M.

    Eur Urol. 2012 Feb;61(2):237-42. Epub 2011 Oct 21.

    PMID:
    22033174
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review.

    Zuiverloon TC, Nieuweboer AJ, Vékony H, Kirkels WJ, Bangma CH, Zwarthoff EC.

    Eur Urol. 2012 Jan;61(1):128-45. Epub 2011 Oct 6. Review.

    PMID:
    22000498
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    Words of wisdom. Re: International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

    Pouessel D, Culine S, Mongiat-Artus P.

    Eur Urol. 2011 Oct;60(4):870-1. No abstract available.

    PMID:
    21878198
    [PubMed]

    Related citations

    19.

    Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer.

    Roscigno M, Brausi M, Heidenreich A, Lotan Y, Margulis V, Shariat SF, Van Poppel H, Zigeuner R.

    Eur Urol. 2011 Oct;60(4):776-83. Epub 2011 Jul 14. Review.

    PMID:
    21798659
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Postoperative intravesical therapy to prevent bladder tumor recurrence: are we ready to listen yet?

    Boorjian SA.

    Eur Urol. 2011 Oct;60(4):711-2. Epub 2011 Jun 22. No abstract available.

    PMID:
    21715085
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk